+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Anti-Ageing Treatment Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 196 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904674
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The anti-ageing treatment market is rapidly redefining modern skincare, as industry participants align to deliver advanced, safe, and minimally invasive solutions tailored for long-term skin health. Strategic innovation and responsive portfolio management are now essential for leaders seeking competitive advantage amid evolving consumer preferences in this dynamic sector.

Market Snapshot: Anti-Ageing Treatment Market Size and Growth

The anti-ageing treatment market is set to grow from USD 50.30 billion in 2024 to USD 52.91 billion in 2025, achieving sustained momentum with a CAGR of 5.22% and reaching USD 75.58 billion by 2032. This expansion reflects transformative advances in dermatology, increasing convergence of preventative and restorative therapies, and diversification of the end-user base across major regions. Leading companies continually invest in cutting-edge research, responding to heightened demand for individualized, science-backed regimens and driving the next phase of industry evolution.

Scope & Segmentation

  • Treatment Types: Encompasses a broad suite of cosmetic procedures such as chemical peels, microneedling, cryotherapy, botox injections, dermal fillers, laser skin resurfacing, microdermabrasion, and radiofrequency technologies. Topical interventions include anti-aging creams, serums, antioxidants, peptides, retinoids, and sunscreens, reflecting a mix of in-clinic and at-home applications.
  • Gender: Addresses both female and male consumer segments, each with distinct purchasing and usage patterns shaped by demographic, cultural, and societal influences. Businesses need to customize outreach and product development accordingly.
  • Distribution Channels: Covers online platforms—brand websites, e-marketplaces—and brick-and-mortar outlets such as pharmacies, drug stores, and specialty retailers. The rise of digital touchpoints facilitates greater brand-consumer interaction and access.
  • End User Applications: Targets comprehensive care including body, eye, and facial treatments, underlining the importance of localized product innovation and service positioning.
  • Regional Coverage: Features an extensive global footprint: Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru); EMEA (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan). Expanding regional diversity supports varied growth trajectories and adapts to differing regulatory landscapes and consumer behaviors.
  • Industry Participants: Includes global leaders such as L'Oréal S.A., The Procter & Gamble Company, Estée Lauder Companies Inc., Unilever PLC, Shiseido Company, Johnson & Johnson Services, Amorepacific, Beiersdorf, KAO, and LG Household & Health Care, driving innovation and best practice adoption throughout the value chain.

Key Takeaways: Strategic Insights for Senior Stakeholders

  • Digital health integration is enabling both clinical and home-based anti-ageing regimens to deliver more personalized, measurable outcomes, creating new value propositions in the market.
  • Evolving regulatory frameworks are being adapted to ensure that innovative modalities reach the market rapidly while maintaining high safety standards, influencing pathways for product approval and commercialization.
  • Heightened sustainability focus leads to prioritization of eco-friendly packaging and responsibly sourced ingredients, supporting market differentiation and appealing to socially conscious buyers.
  • Strategic collaborations between established brands and biotech startups accelerate the development of next-generation products, fostering a more agile innovation cycle.
  • Increased competition from digital-first entrants and direct-to-consumer models is prompting market leaders to refine value propositions and diversify channel strategies to maintain share.

Tariff Impact and Supply Chain Adaptation

The 2025 expansion of US trade tariffs on imported anti-ageing devices and ingredients places added cost pressures on manufacturers and clinics. Market participants are responding by shifting towards nearshoring and domestic production to bolster supply chain resilience. These measures have further triggered increased R&D in alternative materials and more robust cross-border partnerships, safeguarding continued access to crucial therapies and technologies, despite protectionist market dynamics.

Methodology & Data Sources

This research leverages a mixed-methods approach, combining qualitative interviews with healthcare experts and industry leaders with quantitative stakeholder surveys. Supplemented by secondary analyses of leading industry publications and regulatory filings, the methodology supports robust data triangulation and scenario modeling, resulting in actionable findings tailored for decision-makers.

Why This Report Matters for Strategic Decision-Makers

  • Detailed segmentation and global coverage enable stakeholders to identify growth drivers, tailor product development, and capture emerging opportunities in diverse regions.
  • Analysis of regulatory and supply chain scenarios supports proactive risk management and positions organizations to adapt rapidly in changing environments.
  • Comprehensive profiling of competitive trends and partnership activity provides actionable intelligence to inform investment and strategic alignment initiatives.

Conclusion

With these insights, organizations are equipped to lead confidently through the complexities of the anti-ageing market. The report provides a framework for strategic planning and sustained growth in a landscape shaped by ongoing scientific and commercial evolution.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Increasing consumer adoption of personalized peptide-based serums for skin rejuvenation
5.2. Rapid growth of at-home radiofrequency and microcurrent devices for facial lifting
5.3. Surge in clinical trials exploring CRISPR-based gene therapies targeting skin aging biomarkers
5.4. Rising demand for multifunctional SPF and antioxidant-infused daily anti-ageing moisturizers
5.5. Integration of AI-based skin diagnostic apps driving personalized regimen recommendations
5.6. Emerging interest in mitochondrial-targeting peptides to combat oxidative skin damage
5.7. Expansion of clean label formulations with upcycled botanical extracts for age defence
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Anti-Ageing Treatment Market, by Treatment Type
8.1. Cosmetic Treatments
8.1.1. Chemical Peels
8.1.2. Cryotherapy
8.1.3. Dermal Fillers
8.1.4. Dotox Injections
8.1.5. Laser Skin Resurfacing
8.1.6. Microdermabrasion
8.1.7. Microneedling
8.1.8. Radiofrequency Skin Tightening
8.2. Topical Treatments
8.2.1. Anti-aging Creams & Serums
8.2.2. Antioxidants
8.2.3. Peptides
8.2.4. Retinoids
8.2.5. Sunscreens
9. Anti-Ageing Treatment Market, by Gender
9.1. Female
9.2. Male
10. Anti-Ageing Treatment Market, by Distribution Channel
10.1. Online
10.1.1. Brand Websites
10.1.2. E Marketplaces
10.2. Pharmacies & Drug Stores
10.3. Specialty Stores
11. Anti-Ageing Treatment Market, by End User Application
11.1. Body Care
11.2. Eye Care
11.3. Facial Care
12. Anti-Ageing Treatment Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Anti-Ageing Treatment Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Anti-Ageing Treatment Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. L'Oréal S.A.
15.3.2. The Procter & Gamble Company
15.3.3. Estée Lauder Companies Inc.
15.3.4. Unilever PLC
15.3.5. Shiseido Company, Limited
15.3.6. Johnson & Johnson Services, Inc.
15.3.7. Amorepacific Corporation
15.3.8. Beiersdorf AG
15.3.9. KAO Corporation
15.3.10. LG Household & Health Care Ltd.
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Anti-Ageing Treatment market report include:
  • L'Oréal S.A.
  • The Procter & Gamble Company
  • Estée Lauder Companies Inc.
  • Unilever PLC
  • Shiseido Company, Limited
  • Johnson & Johnson Services, Inc.
  • Amorepacific Corporation
  • Beiersdorf AG
  • KAO Corporation
  • LG Household & Health Care Ltd.

Table Information